BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2902612)

  • 1. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH; Kempf P; Mössinger B; Klein G; Costabel U; Würtemberger G; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract]   [Full Text] [Related]  

  • 4. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 5. Undetermined utility of almitrine.
    Patz D
    Chest; 1987 May; 91(5):794. PubMed ID: 2882957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of almitrine dimesylate on gas exchange. Preliminary results in patients with chronic obstructive bronchopneumopathies under artificial ventilation].
    Castaing Y; Manier G; Guenard H
    Presse Med; 1984 Oct; 13(34):2078-82. PubMed ID: 6149535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Almitrine dimesylate: ventilatory or vascular action].
    Préfaut C; Bourgouin-Karaouni D
    Rev Med Interne; 1985; 6 Spec No():3-7. PubMed ID: 3914681
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Originality of the mode of action of almitrine dimesylate].
    Tellier P
    Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y; Manier G; Varène N; Guénard H
    Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical bases for the respiratory action of almitrine].
    Lecomte J; Lagneaux D
    Rev Med Liege; 1986 May; 41(10):451-5. PubMed ID: 2874604
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
    Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG
    Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis and criticism of hemodynamic investigations during respiratory analeptic dispensing (author's transl)].
    Daijardin JB; Pourriat JL; Hoang P; Lapandry C; Cupa M
    Anesth Analg (Paris); 1980; 37(9-10):557-60. PubMed ID: 6110386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C
    Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of almitrine bismesylate.
    Pariente R
    Eur J Respir Dis Suppl; 1983; 126():271-4. PubMed ID: 6586441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.